• GI Innovation expects a USD 3.5 million milestone payment from Japan's Maruho under its October 16, 2023, GI-301 licensing agreement.
• The milestone was triggered by dosing the first patient in a Phase 2 trial in Japan.
• Payment is due within 60 days of the October 23, 2026, invoice date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GI Innovation Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261023900503), on October 23, 2026, and is solely responsible for the information contained therein.